Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. (Q53668906)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 December 2014

Language	Label	Description	Also known as
English	Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.	scientific article published on 18 December 2014

Statements

scholarly article

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. (English)

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

1 reference

based on heuristic

inferred from title

author name string

Isabelle Matte

1

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Denis Lane

2

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Claude Laplante

3

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Perrine Garde-Granger

4

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Claudine Rancourt

5

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Alain Piché

6

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

language of work or name

0 references

publication date

18 December 2014

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

137

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

2

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

289-298

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Epithelial ovarian cancer: prevention, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Tumor-stroma interactions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

The microenvironment of the tumour-host interface

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Malignant effusions: from diagnosis to biology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Role of malignant ascites on human mesothelial cells and their gene expression profiles

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

The emerging role of lysophosphatidic acid in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Malignant ascites: a 2-year review from a teaching hospital

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Epithelial-mesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29385

21 January 2018

Identifiers

10.1002/IJC.29385

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

1 reference

Europe PubMed Central

17 May 2018

http://europepmc.org/abstract/MED/25482018

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53668906&oldid=1773299280"